Russo R, Ryffel B
Cells. 2025; 13(24).
PMID: 39768150
PMC: 11674266.
DOI: 10.3390/cells13242058.
Juvkam I, Zlygosteva O, Sitarz M, Sorensen B, Aass H, Edin N
Sci Rep. 2024; 14(1):22311.
PMID: 39333378
PMC: 11437014.
DOI: 10.1038/s41598-024-73110-7.
Hamdi E, Bekhit A, Higazi A, Ahmed A, Hussein Kasem A, Najim M
Saudi Pharm J. 2023; 31(11):101816.
PMID: 37876736
PMC: 10590737.
DOI: 10.1016/j.jsps.2023.101816.
Hegazy W, Sakr H, Abdul Hamid M, A Abdelaziz M, Salah M, Abdel Rehiem E
Biomedicines. 2023; 11(6).
PMID: 37371665
PMC: 10295994.
DOI: 10.3390/biomedicines11061570.
He X, Jarrell Z, Smith M, Thi Ly V, Hu X, Sueblinvong V
Am J Physiol Lung Cell Mol Physiol. 2023; 325(2):L215-L232.
PMID: 37310758
PMC: 10396228.
DOI: 10.1152/ajplung.00303.2022.
Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2.
Begum R, Mamun-Or-Rashid A, Lucy T, Pramanik M, Sil B, Mukerjee N
Molecules. 2022; 27(20).
PMID: 36296527
PMC: 9609612.
DOI: 10.3390/molecules27206934.
Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis.
Sehgal M, Jakhete S, Manekar A, Sasikumar S
Heliyon. 2022; 8(8):e09773.
PMID: 36061031
PMC: 9434059.
DOI: 10.1016/j.heliyon.2022.e09773.
Single-Cell Transcriptome Analysis Reveals the Role of Pancreatic Secretome in COVID-19 Associated Multi-organ Dysfunctions.
Pathak E, Atri N, Mishra R
Interdiscip Sci. 2022; 14(4):863-878.
PMID: 35394619
PMC: 8990272.
DOI: 10.1007/s12539-022-00513-3.
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review.
Bergantini L, Mainardi A, DAlessandro M, Cameli P, Bennett D, Bargagli E
Front Pharmacol. 2022; 13:748931.
PMID: 35308222
PMC: 8931519.
DOI: 10.3389/fphar.2022.748931.
Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.
Salvi S, Ghorpade D, Dhoori S, Dhar R, Dumra H, Chhajed P
Lung India. 2022; 39(2):177-186.
PMID: 35259802
PMC: 9053913.
DOI: 10.4103/lungindia.lungindia_659_21.
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.
Giacomelli C, Piccarducci R, Marchetti L, Romei C, Martini C
Biochem Pharmacol. 2021; 193:114812.
PMID: 34687672
PMC: 8546906.
DOI: 10.1016/j.bcp.2021.114812.
Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges.
Hakim A, Hasan M, Hasan M, Lokman S, Azim K, Raihan T
Front Microbiol. 2021; 12:637554.
PMID: 34512561
PMC: 8424194.
DOI: 10.3389/fmicb.2021.637554.
An overview of some potential immunotherapeutic options against COVID-19.
Bayat M, Asemani Y, Mohammadi M, Sanaei M, Namvarpour M, Eftekhari R
Int Immunopharmacol. 2021; 95:107516.
PMID: 33765610
PMC: 7908848.
DOI: 10.1016/j.intimp.2021.107516.
The second wave of desaturation in coronavirus disease 2019.
Alghizzawi M, Ata F, Yousaf Z, Alhiyari M, Bint I Bilal A, Elhiday A
New Microbes New Infect. 2021; 41:100866.
PMID: 33758668
PMC: 7972827.
DOI: 10.1016/j.nmni.2021.100866.
Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge.
Prakash J, Bhattacharya P, Priye S, Kumar N
Indian J Crit Care Med. 2021; 25(1):104-105.
PMID: 33603312
PMC: 7874295.
DOI: 10.5005/jp-journals-10071-23709.
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection.
Lechowicz K, Drozdzal S, Machaj F, Rosik J, Szostak B, Zegan-Baranska M
J Clin Med. 2020; 9(6).
PMID: 32575380
PMC: 7356800.
DOI: 10.3390/jcm9061917.
An overview of COVID-19.
Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H
J Zhejiang Univ Sci B. 2020; 21(5):343-360.
PMID: 32425000
PMC: 7205601.
DOI: 10.1631/jzus.B2000083.
Blood Levels of IL-Iβ, IL-6, IL-8, TNF-α, and MCP-1 in Pneumoconiosis Patients Exposed to Inorganic Dusts.
Lee J, Shin J, Lee J, Lee W, Hwang J, Kim J
Toxicol Res. 2020; 25(4):217-224.
PMID: 32038841
PMC: 7006313.
DOI: 10.5487/TR.2009.25.4.217.
In Vivo Endomicroscopy of Lung Injury and Repair in ARDS: Potential Added Value to Current Imaging.
Lesur O, Chagnon F, Lebel R, Lepage M
J Clin Med. 2019; 8(8).
PMID: 31405200
PMC: 6723156.
DOI: 10.3390/jcm8081197.
Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis.
Ni W, Yang D, Mei H, Zhao J, Liang B, Bai N
Antimicrob Agents Chemother. 2017; 61(4).
PMID: 28115351
PMC: 5365682.
DOI: 10.1128/AAC.01936-16.